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T cell antigen receptor (TCR) and coreceptor ligation
is thought to initiate signal transduction by inducing
activation of the kinase Lck. Here we showed that
catalytically active Lck was present in unstimulated
naive T cells and thymocytes and was readily detect-
able in these cells in lymphoid organs. In naive T cells
up to 40% of total Lck was constitutively activated,
part of which was also phosphorylated on the
C-terminal inhibitory site. Formation of activated
Lck was independent of TCR and coreceptors but
required Lck catalytic activity and its maintenance
relied on monitoring by the HSP90-CDC37 chaperone
complex to avoid degradation. The amount of acti-
vated Lck did not change after TCR and coreceptor
engagement; however it determined the extent of
TCR-z phosphorylation. Our findings suggest a
dynamic regulation of Lck activity that can be
promptly utilized to initiate T cell activation and have
implications for signaling by other immune receptors.INTRODUCTION
Src family kinases (SFKs) couple many cell-surface receptors to
the intracellular signaling machinery to regulate proliferation,
differentiation, survival, and adhesion dynamics (Bromann
et al., 2004; Parsons and Parsons, 2004). This SFK’s multitasking
ability probably reflects versatility in substrate targeting and cell
context-specific regulation. T cell receptor (TCR) signaling upon
peptide-MHC (pMHC) binding requires phosphorylation of
immunoreceptor tyrosine-based activation motifs (ITAMs) within
the CD3 complex by the SFK Lck (Palacios and Weiss, 2004).
Phosphorylated ITAMs recruit and activate the Syk protein
tyrosine kinase (PTK) ZAP-70 to set in motion pathways that
orchestrate T cell proliferation and differentiation (Acuto et al.,
2008; Au-Yeung et al., 2009). Conventional views of T cell activa-
tion suggest that pMHC binding activates Lck. However, a mech-766 Immunity 32, 766–777, June 25, 2010 ª2010 Elsevier Inc.anistic basis for this model, implying a direct link between TCR
and Lck, is lacking. Because Lck is stably associated to the
coreceptors CD4 and CD8 (Rudd et al., 1988; Veillette et al.,
1988), other models have suggested that binding to MHC
activates Lck by trans-autophosphorylation. Indeed, coreceptor
oligomerization by antibody crosslinking induces increased Lck
tyrosine phosphorylation and activity (Holdorf et al., 2002;
Veillette et al., 1989). However, structural and membrane
biophysical studies do not support the existence of stable and/
or abundant MHC dimers or oligomers (Baker and Wiley, 2001;
Cherry et al., 1998), and there is no direct experimental evidence
that MHC binding activates Lck. Moreover, coreceptors are
partially dispensable for T cell development and activation (Van
Laethem et al., 2007). Thus, the lack of strong experimental
support for these models leaves unanswered the central mech-
anism that initiates TCR-mediated adaptive immunity.
The activity of SFKs is largely controlled by the equilibrium
between phosphorylation and dephosphorylation at a C-terminal
inhibitory tyrosine and an activating tyrosine in the catalytic
domain (Boggon and Eck, 2004; Yamaguchi and Hendrickson,
1996). When phosphorylated by the C-terminal Src-kinase
(Csk), the C-terminal tyrosine binds intramolecularly to the SH2
domain (Xu et al., 1999), which, together with the SH3 domain
interacting with a PPII a-helix packed against the kinase domain,
locks SFKs into an autoinhibited closed form (Boggon and
Eck, 2004). The SH3-SH2 ‘‘clamp’’ must be released to initiate
activation. Dephosphorylation of the C-terminal tyrosine by
membrane-bound protein tyrosine phosphatases (e.g., PTPa,
CD45) helps relax the closed form (Hermiston et al., 2003; Su
et al., 1999). Kinase unwinding may be also favored by binding
of the SH3-SH2 module to substrate(s) or regulatory partner(s)
(Boggon and Eck, 2004). However, catalytic activation entails
tyrosine phosphorylation at the activation loop to precisely
position the ATP phosphates, the amino acids involved in catal-
ysis, and the substrate (Boggon and Eck, 2004). Ligand-induced
collision of receptor-associated SFKs may lead to trans-auto-
phosphorylation of the activation loop. Alternatively, SFKs may
be activated by receptor tyrosine kinases (RTKs) after binding
to them (Bromann et al., 2004). However, the exact mechanism
of these processes that usually induce modest SFK activation
is unclear (discussed in Bromann et al., 2004), and thus far it is
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Lck Regulation in T Cellsunknown whether SFK activation is exclusively instructed by
external stimuli.
We previously reported biochemical evidence for the pres-
ence of activated Lck (pY394-Lck) in transformed human T cell
lines and normal T cells prior to TCR stimulation (Irles et al.,
2003). More recently, Alexander and coworkers (McNeill et al.,
2007) also detected activated SFKs in isolated mouse primary
T cells and thymocytes. However, the lack of evidence that acti-
vated Lck is expressed in unstimulated cells in vivo and lack of
quantification of activated Lck precluded reaching any conclu-
sion on the relevance and consequences of these observations.
Here, we showed that relatively high amounts of pY394-Lck (and
pY418-Fyn) are expressed in T cells and thymocytes in isolation
and in situ in lymphoid tissues. B cells also do express preacti-
vated SFKs, although at lower amounts than T cells (data not
shown). Approximately half of pY394-Lck was a new form phos-
phorylated on both the activation and inhibitory site, which has
kinase activity equivalent to Lck phosphorylated only on Y394.
Basal amounts of pY394-Lck were regulated dynamically by
trans-autophosphorylation and maintained by the HSP90-
CDC37 chaperone complex. Preactivated Lck was sufficient for
inducing activation because TCR ligation did not lead to further
increase of pY394-Lck or its kinase activity. However, reduction
of basal pY394-Lck critically affected TCR signaling initiation
and sensitivity. By revealing a special regulatory mechanism to
maintain activated SFKs in T cells, our data prompt a revision
of the current models of TCR signal transduction.
RESULTS
Activated SFKs Are Expressed in Unstimulated T Cells
and Thymocytes In Vitro and In Vivo
To investigate the regulation of Lck in T cells, we used pY416 Ab
that identifies the activated form of several SFKs, including Lck
(Figure S1A) and pY505 Ab that binds to the phosphorylated
inhibitory site of Lck. Specificity controls excluded undesirable
cross-reactivities of these reagents (see ‘‘Specificity of Anti-
pY416 and Anti-pY505-Lck Abs in Immunoblot and Immunoflu-
orescence’’ in Supplemental Results and Figures S1B–S1E
available online). The pY416 Ab readily detected activated Lck
(pY394-Lck) in cell lysates of unstimulated Jurkat cells, human
and mouse T cells and thymocytes (Figure 1A). The identity of
the activated Lck was confirmed by anti-Lck immunoprecipita-
tion followed by anti-pY416 immunoblotting (Figure S1F). The
59 kDa species reacting with anti-pY416, more prominent in
human CD4+ T cells and mouse thymocytes, was identified as
being activated Fyn (pY418-Fyn) (Figure S1F). Cell culture (e.g.,
serum-free or serum-enriched medium) or lysis conditions
(e.g., ice-cold lysis or at 100C in Laemmli sample buffer) did
not appear to alter the amounts of activated SFKs (not shown).
In contrast, cultured HeLa cells showed barely detectable acti-
vated Fyn (Figure S1F). These results are indicative of differential
regulation mechanisms of SFK activity within distinct cell types.
Immunofluorescence (IF) analysis of human CD4+ T cells with
Lck or pY416 Abs intensely stained the cell surface decorated for
CD4 (Figure 1B), consistent with Lck and activated SFKs being
present mostly at the plasma membrane. To directly identify
active Lck in intact cells, we carried out IF colocalization studies
with Lck and pY416 Abs (Figure 1C). Control double staining withtwo distinct Lck Abs gave, as expected, high colocalization
(Pearson’s correlation coefficient, Rr. close to 1.0), whereas
Lck and Filamin A showed poor colocalization as predicted for
two spatially distant proteins. Staining with pY416 and Lck Abs
showed strong colocalization indicating, in accordance with
the immunoblot data, the presence of activated Lck. Separate
Lck (green) or pY416 (red) pixels were presumably due, in part,
to nonactivated Lck and activated Fyn, respectively. Collec-
tively, these data indicated that cultured unstimulated T cells
and thymocytes expressed activated forms of SFKs, confirming
and extending previous in vitro studies (Irles et al., 2003; McNeill
et al., 2007). It was crucial to determine whether activated SFKs
were also present in intact lymphoid tissues. To this purpose, we
carried out in situ staining with anti-pY416 in the mouse spleen,
lymph node (LN), and thymus. Anti-pY416 stained the majority of
CD4+ T cells and thymocytes (Figure 1D). Similar data were
obtained for CD8+ T cells (not shown). Moreover, similar T cell
staining with anti-pY416 was observed when tissues were
obtained from paraformaldehyde (PFA)-perfused animals (not
shown), excluding changes during manipulation. Pretreatment
with alkaline phosphatase (AP) abolished anti-pY416 reactivity
(Figure S1E), providing a control for the specificity of the in situ
staining. To quantitatively link activated SFK detected in situ
and in vitro, we directly compared staining with anti-pY416
in situ in spleen and in cells isolated from part of the same organ
(Supplemental Experimental Procedures). Parallel staining with
anti-pY416 revealed similar fluorescence intensity (Figure S1G),
excluding that the amount of activated SFKs substantially
changed during cell isolation. Taken together, these data pro-
vided evidence that normal T cells and thymocytes do express
in vivo activated SFKs, including Lck and Fyn.
Quantification of Activated Lck in T Cells
The apparent abundance of activated Lck in T cells prompted us
to estimate its relative proportion over total Lck. To this end, we
initially carried out immunodepletions of pY394-Lck from Jurkat
lysates by using anti-pY416 and measured the loss of Lck by
anti-Lck quantitative immunoblotting (Figure 2A). We used dena-
tured lysates to rule out coimmunoprecipitation of potentially
occurring oligomers of Lck forms. Control experiments revealed
negligible levels (1%–2%) of inactive Lck (Y394-Lck) carried
over by anti-pY416 depletions (Figure S2A and S2B). In Jurkat
cells, depleting >90% of pY394-Lck, resulted in a >50% reduc-
tion of total Lck (56% ± SD 2.1% [n = 3]), indicating that more
than half of Lck was phosphorylated on Y394 (Figure 2A). Similar
results were obtained with nondenatured cell lysates (data not
shown).
To validate the immunodepletion data in Jurkat cells by an
independent approach, we estimated pY394-Lck over total
Lck by mass spectrometry (MS) by using Absolute Quantification
(AQUA) (Gerber et al., 2003). Because of the partial digestion of
the tryptic peptide containing phosphorylated Y394, an indirect
but reliable procedure was preferred (see Supplemental Experi-
mental Procedures). Thus, a heavy isotope-labeled peptide,
[L-C13N15]IEDNEYTAR, corresponding to the Lck tryptic frag-
ment containing nonphosphorylated Y394 was used for quanti-
fying Lck in samples untreated or treated with AP, which dephos-
phorylates pY394 (Figure 2C). The difference between these
two measures provided an estimate of pY394-Lck. TheImmunity 32, 766–777, June 25, 2010 ª2010 Elsevier Inc. 767
Figure 1. Activated SFKs in T Cells and Thymocytes
(A) Dual fluorescence immunoblot (IB) for Lck (green) and pY416 (red) in Jurkat cells, TCR-, CD4-, and CD8-deficient 31.13 (TCR-) and TCR-reconstituted 31.13
(TCR+) Jurkat cells, human and mouse CD4+ and CD8+ T cells, and mouse thymocytes from normal and Rag1/ mice. Merged (yellow) denotes expression of
pY394-Lck (see Figure S1C). The 59 kDa species is mostly pY418-Fyn.
(B) Confocal IF of human CD4+ T cells stained for CD4 and either for Lck or active SFKs (pY416). Nuclei were counterstained with Hoechst 33258 (blue). The scale
bar represents 3.5 mm.
(C) Confocal IF for Lck forms in human CD4+ T cells. Double staining with two different Abs to Lck, a rabbit Ab (red) and a mouse mAb (green) (first row), was used
as the positive control for colocalization. Double staining with a rabbit Ab to Lck (green) and a mAb to Filamin A (red) (bottom row) was the negative control (lack of
colocalization). The presence of pY394-Lck was identified by double staining with Lck mAb (green) and pY416 rabbit Ab (red) (second row). For pY394 and pY505
colocalization (third row), we used anti-pY416 rabbit Ab (green) and anti-pY505 mAb (red). The degree of colocalization was determined with Imaris colocalization
software. Corresponding pictures were merged (third column) and all pixels colocalized were represented as white spots (fourth column). Each colocalized pixel
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Figure 2. Quantification of pY394-Lck and
pY505-Lck in T Cells
(A and B) Denatured lysates from (A) Jurkat cells or
(B) human CD4+ T cells were split into two halves
and subjected to three rounds of immunoprecipi-
tations (IP) with pY416 Ab (pY416) or rabbit IgG
(Control), respectively. Lysates were analyzed by
immunoblotting (IB) for residual pY394-Lck, Lck,
and pY505-Lck. The loading control was ZAP-
70. IBs were scanned for fluorescence and
relevant bands were quantified. Numbers below
each panel correspond to the actual fluorescence
signals.
(C) Lck isolated from Jurkat cells with the 3A5 mAb
was split in two and incubated with (AP) or without
(Ctr) alkaline phosphatase for 30 min at 37C. The
fraction of pY394 dephosphorylated was deter-
mined by immunoblotting (left panel). Lck from
107 cells (twice for each condition) was in-gel
digested with trypsin, after spiking with 1 pmol of
[L-C13N15] IEDNEYTAR.Eachsample was analyzed
twice by MS. Histogram represents mean pico-
moles ± SE, n = 4 of endogenous LIEDNEYTAR in
AP-treated and untreated samples. Details of
AQUA and MS are available in the Supplemental
Information.
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Lck Regulation in T Cellsexperiment in Figure 2C showed that AP treatment (87%
dephosphorylation of pY394) increased the amount of Y394-
Lck from 1.0 to 1.7 pmoles. After correction for 100%
dephosphorylation, Lck amounted to 1.9 pmoles, which trans-
lated into 0.9 pmoles of pY394-Lck, 47% (0.9/1.9) of total Lck, in
good agreement with the immunodepletion data. Anti-pY416 im-
munodepletion of human naive CD4+ T cell lysates (one of which
is illustrated in Figure 2B) indicated that 37% ± 8.5% (n = 3) of
Lck was activated, with some variability between donors.
To corroborate these data, we compared by immunoblotting
pY394-Lck/Lck ratio in Jurkat cells (used as a reference for the
proportion of active Lck over the total Lck, e.g., 56%) to the
pY394-Lck/Lck ratios in human naive CD4+ T cells from four
additional donors (Figure S2C). CD4+ T cell content of activated
Lck was 65% of that found in Jurkat cells. This translates into
36% ± 4.3% (n = 4) of activated Lck in normal T cells, in agree-
ment with the immunodepletion experiments. Comprehensively,was plotted on a scatter diagram for producing correlation plots with colocalizing pixels falling around the diag
cells for each condition were used for calculating the Pearson’s correlation coefficient (Rr) as mean ± SE p valu
scale bar represents 3.5 mm.
(D) Confocal IF images of a mouse spleen, LN, and thymus. Tissue sections (10 mm) were stained with biotin-la
(rabbit) (green). The scale bar represents 10 mm. Images are representative of three independent experimen
Immunity 32, 766–7these data indicated that Jurkat and
normal T cells can express activated
Lck in a high proportion, yet they do not
become spontaneously activated.
Activated Lck Exists in Two Major
Forms
pY505-Lck should represent inactive
Lck. To estimate its relative proportion
with respect to active Lck, we carriedout depletion experiments by using pY505 Ab (Figures 3A and
3B). We found that 52% ± 2.6% (n = 3) and 35% ± 4.6% (n =
3) of total Lck was phosphorylated at pY505 in Jurkat and naive
human CD4+ T cells, respectively. Quantitative immunoblot
experiments comparing pY505/Lck ratios (Figure S2D) indicated
that human naive CD4+ T cells contained56% of the pY505 ex-
pressed in Jurkat cells, giving 30% ± 8.2% (n = 4) of pY505-Lck,
in good agreement with the immunodepletion data. However, we
noticed that complete removal of pY394-Lck in Jurkat cells led
also to a loss of 50% of pY505-Lck (Figure 2A, bottom panel)
and depletion of pY505-Lck also removed 50% of pY394-
Lck (Figure 3A, bottom panel). Similar to Jurkat cells, in human
CD4+ T cells approximately half of pY394 or pY505 was removed
after depletion with anti-pY505 and anti-pY416, respectively
(Figures 2B and 3B). Because Lck was denatured, it was unlikely
that active and inactive forms were coimmunoprecipitated and
in such a close proportion with the two Abs. Thus, a likelyonal line (right-hand column). Data from at least 50
es (two-tailed) determined with Student’s t test. The
beled anti-mouse CD4 (L3T4) (red) and anti-pY416
ts.
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Figure 3. A Proportion of Lck Is Phosphory-
lated at Both Y394 and Y505
(A and B) Denatured lysates from (A) Jurkat cells or
(B) human CD4+ T cells were treated as in Figures
2A and 2B but immunoprecipitated with anti-
pY505 rabbit Ab (pY505) or rabbit IgG (Control).
Postdepletion lysates were probed for residual
pY505-Lck, Lck, and pY394-Lck. The loading
control was ZAP-70. Signal intensity was detected
as in Figures 2A and 2B.
(C) Denatured lysates of human CD4+ T cells (left
panels) or total mouse thymocytes (right panels)
were immunoprecipitated with anti-pY505 or
anti-pY416 or rabbit IgG (Control) and immuno-
blotted with anti-pY416 (red) or anti-pY505 (red),
respectively, and with anti-Lck (green). Merged
images (yellow) reveal pY394-Lck containing
pY505 and vice versa.
(D) Native or denatured Jurkat lysates were immu-
noprecipitated three times with anti-pY505 or
rabbit IgG. Immunoprecipitates were pooled,
immunoblotted for pY505, Lck, and pY394-Lck
(with anti-pY416), and quantified. These experi-
ments were performed three times with similar
results.
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Lck Regulation in T Cellsexplanation was that a fraction of pY394-Lck was also phosphor-
ylated at the inhibitory site. This form, pY394-pY505-Lck (here-
after referred as to ‘‘double’’ phosphorylated, DPho-Lck), was
directly demonstrated to exist not only in T cells but also in thymo-
cytes by showing that Lck isolated with anti-pY416 from these
cells contained pY505 and vice versa (Figure 3C). Expression of
DPho-Lck was also confirmed in intact T cells by the strong
colocalization of anti-pY505 and anti-pY416 staining (Figure 1C,
third row). To our knowledge, DPho-Lck has not been noted
before, and it represents a sizable fraction of total Lck (20%–
30%, Table 1 and see ‘‘Estimation of the Relative Proportions
of the Four Lck Forms’’ in Supplemental Results for calculations).
DPho-Lck may be locked in a closed conformation similar to
the inactive form of Lck with the phosphorylated C-terminal
inhibitory site stably interacting with SH2 domain (Xu et al.,
1999) and therefore sterically hindered (Kabouridis, 2003). If770 Immunity 32, 766–777, June 25, 2010 ª2010 Elsevier Inc.however DPho-Lck is in an open confor-
mation, the phosphorylated C-terminal
might react with the pY505 Ab. To test
this idea, we carried out immunodeple-
tions with anti-pY505 of intact and dena-
tured lysates of Jurkat cells and probed
them by immunoblotting for pY394, Lck,
and pY505 (Figure 3D). Under native
conditions, anti-pY505 reacted with Lck
that was also phosphorylated at pY394.
However, not all pY505-Lck could be
depleted (data not shown). After denatur-
ation, anti-pY505 quantitatively immuno-
depleted pY505-Lck and approximately
twice as much pY505 and Lck was found,
although the amount of pY394 remained
essentially unchanged. These data are
consistent with DPho-Lck being in an
open conformation with pY505 disen-gaged from the SH2 domain and thus readily accessible to the
antibody. In contrast, in inactive-closed Lck (Y394-pY505) the
phosphorylated C-terminal is not accessible (see Figure S3
for a scheme of Ab accessibility) and becomes exposed only after
protein denaturation. The data obtained by the immunodeple-
tion experiments shown in Figures 2 and 3 indicated that Lck
exists in four major forms according to the phosphorylation at
the activation and inhibitory sites and provided an estimation of
the proportion of each of them (Table 1 and see ‘‘Estimation of
the Relative Proportions of the Four Lck Forms’’ in Supplemental
Results).
pY394-Lck and DPho-Lck Have Similar In Vitro Kinase
Activity
DPho-Lck appeared to be in an open conformation; thus, we
examined whether it was catalytically active. We used Jurkat
Table 1. T Cells Express Four Major Functional Forms of Lck
Relative Proportion of Lck Forms
in Unstimulated Cellsa
Closed-Inactiveb Primed pY394-Active DPho-Active
Human CD4+
T cells
14% 48% 17% 21%
Jurkat cells 23% 25% 23% 29%
a The calculations of the relative proportions of Lck forms are explained in
‘‘Estimation of the Relative Proportions of the Four Lck Forms’’ in the
Supplemental Results.
b Column headings are described as follows: closed-inactive, Lck retains
the SH2 intramolecular binding and locks the kinase into a catalytically
compromised conformation; primed Lck, phosphorylated neither at
Y505 nor Y394. The SH3 domain-linker binding may still be preserved;
pY394-active, Lck kinase domain assumes an optimal conformation for
catalysis; and DPho-Active, The Dpho-Lck contains both pY394 and
pY505 and assumes an open conformation like pY394-active.
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SFKs. We first employed anti-pY416 and anti-Y416 to isolate
pY394-Lck and Y394-Lck pools, respectively, and compared
their kinase activity on recombinant CD3-z-GST [rCD3-z]). As
expected (Boggon and Eck, 2004), the vast majority of kinase
activity was associated with pY394-Lck (Figure 4A). We next
separated the two Lck forms containing pY394 and compared
their activity on rCD3-z (Figures 4B and 4C). DPho-Lck was
isolated with anti-pY505 and contained mostly pY394-Lck and
only traces of Y394-Lck (Figure 4B). To enrich for pY394-Lck,
we sequentially depleted DPho-Lck with anti-pY505 and then
inactive and primed Lck (Y394-pY505- and Y394-Y505-Lck)
with anti-Y416. The remaining pY394-Lck was then immunopre-
cipitated with anti-Lck and was strongly enriched for pY394/
Y505-Lck (compared with the strong signal of anti-pY416 and
weak signal of anti-pY505 and anti-Y416 in Figure 4B). We found
that DPho-Lck and pY394-Y505-Lck displayed comparable
kinase activity (Figure 4C, lanes 1 and 2) and correlated with
similar amounts of pY394-Lck in both fractions (Figure 4C).
Thus, activated Lck is found in two forms that appear to have
similar capacity to phosphorylate TCR ITAMs and are present
in nonstimulated T cells in a high proportion.
Regulation of Basally Activated Lck in T Cells
In view of our data, we examined which mechanisms might be
responsible for generating and maintaining basally active Lck.
One hypothesis is that activated SFKs might be controlled by
TCR and/or coreceptor interactions with self-pMHC. However,
we detected high amounts of activated Lck in CD4 and CD8-
negative (double negative [DN]) thymocytes from Rag-deficient
mice that lack expression of pre-TCR (Figure 1A) and in DN
thymocytes from normal mice (not shown). Moreover, compa-
rable amounts of pY394-Lck were found in cultured Jurkat cells
irrespective of TCR, CD4, and CD8 expression (Figure 1A). Acti-
vated Lck and Fyn persisted in blood-derived human naive
T cells (depleted of MHC class II-expressing cells) (Figure 1A)
after several hours of diluted cultures, conditions in which the
TCR or CD4 are unlikely to be engaged. Furthermore, CD4 IPs
from Jurkat cells did not show any preferential binding of active
Lck to the coreceptor (Figure S4). Thus, expression of activatedSFKs did not appear to depend on TCR or CD4 and CD8 core-
ceptor expression and/or their contact with pMHC.
SFK activation may be attributable to trans-autophosphoryla-
tion at the conserved activation loop tyrosine (Palacios and
Weiss, 2004). To test this hypothesis, we treated Jurkat cells
with various concentrations of PP2, a very potent and specific
inhibitor of SFKs, or PP3, an inactive PP2 analog, as a control.
Cellular amounts of activated Lck decayed with an exceptionally
fast half-life (30 s) at all doses of PP2 tested (Figure 5A), reach-
ing different basal amounts. These data suggested that Lck
kinase activity is critical to maintain its own basal activated
state that is tightly and very dynamically controlled by a potent
PTPase, plausibly CD45 (McNeill et al., 2007).
Previous work has established that the stability and expres-
sion of constitutively active Lck mutants require association
with the HSP90-CDC37 chaperone complex (Giannini and
Bijlmakers, 2004; Prince and Matts, 2004). We therefore investi-
gated whether this was also the case for basally activated Lck by
treating cells with geldanamycin, a specific inhibitor of HSP90
binding to client proteins (Giannini and Bijlmakers, 2004). Treat-
ment of Jurkat cells with geldanamycin for 3 hr resulted in
a dramatic decrease of pY394-Lck (90%) concomitant with
a 50% loss of the total Lck (Figure 5B), coincident with
50% of Lck being in the active form in Jurkat cells (Table 1).
In contrast, little or no degradation of Lck, in response to gelda-
namycin, was observed in J45 cells, which express markedly
reduced amounts of CD45 (Koretzky et al., 1991), (Figure 5C).
In this cell line, the majority of Lck is phosphorylated on Y505
thus existing in the closed-inactive conformation and containing
very small amounts of activated Lck compared to Jurkat (data
not shown). Similarly, little loss of Lck after geldanamycin treat-
ment was observed in Jurkat cells treated with PP2 (Figure 5C),
with the latter resulting in >80% reduction on the basal level of
pY394-Lck (data not shown). These data suggest that constant
monitoring by the HSP90-CDC37 chaperone complex is essen-
tial for preserving the basal amounts of activated Lck by means
of protecting it from proteolytic degradation.
TCR Signaling Does Not Increase but Requires Basally
Activated Lck
The relatively high amount of activated Lck in T cells raised the
question as to whether TCR-induced activation required further
increase in Lck activity. We employed different stimulation
settings of Jurkat cells as well as human and mouse T cells, by
using anti-CD3, Staphylococcus enterotoxin superantigen
(sAg)-MHC class II and peptide-MHC class I, respectively. The
latter two forms of stimulation involved coreceptor recruitment
near the TCR. Activation of Jurkat cells with saturating anti-
CD3 strongly increased tyrosine phosphorylation of CD3-z
(pY142-z) and LAT. However, no reproducible trend was seen
toward augmentation of the pY394-Lck/Lck ratio ( ±10%)
(Figure 6A), and only small variations around the mean were
observed in many experiments. Consistently, no appreciable
change of the in vitro kinase activity was recorded within the
pY394, total Lck, or the Y394-Lck fractions (Figure S5). Also,
we did not observe reproducible changes in pY505 amounts
at these time points (data not shown). Human CD4+ T cells
were stimulated with sAgs-pre-pulsed Raji B cells, conditions
that activated most cells (>80%). Whereas sAg stimulationImmunity 32, 766–777, June 25, 2010 ª2010 Elsevier Inc. 771
Figure 4. Catalytic Activity of Dpho-Lck
(A) Lck activity is mostly associated with pY394-
Lck. Jurkat lysates were immunoprecipitated
with anti-pY416 or anti-Y416 or with control IgG
(Control) and subjected to in vitro kinase assay
on rCD3-z-GST. The reaction mixture was immu-
noblotted for pY142-z, GST, pY394 (pY416), and
Lck and quantified by near-infrared fluorescence
(numbers below each panel). Overlapping Lck
and pY416 fluorescence (not shown) provide posi-
tive identification of pY394-Lck. Kinase activity
(right panel) was expressed as pY142-z signal
subtracted for IgG control and normalized for
rCD3-z-GST.
(B and C) Dpho- and pY394/Y505-Lck have similar
kinase activity. As shown in (B), DPho (pY394-
pY505) and pY394 (pY394-Y505) were individually
enriched by immunoprecipitation (see Results). An
aliquot was subjected to dual fluorescence immu-
noblotting with anti-pY416 (red) and anti-Y416
(green) or anti-pY505 (red) and anti-Lck (green).
The control was rabbit IgG. In (C), Dpho- and
pY394-Lck from (B) and IgG control immunopre-
cipitations were assayed for kinase activity on
rCD3-z-GST as in (A) and immunoblotted for
pY142-z, GST and pY394 (pY416). Identification
of pY394-Lck was as in (A). A representative
experiment of three giving similar results is shown.
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points, no augmentation in pY394-Lck content was detected
(Figure 6B). Moreover, 2D1 TCR-tg mouse CD8+ T cells (Friese
et al., 2008) stimulated with activated B cells loaded with
a maximal dose of agonist antigen peptide presented by class
I MHC induced CD3-z and LAT tyrosine phosphorylation without
substantial change in the pY394-Lck content (Figure 6C). Finally,
pY394-Lck did not increase when 2D1 TCR-tg CD8+ T cells were
stimulated with a saturating dose of a strong agonist tetramer
A3-PLP-MHC class-I (Figure 6D). In addition, quantitative con-
focal IF analysis of anti-CD3 stimulated human CD4+ T cells
revealed no changes in the fluorescence intensity of pY416 or
pY505 staining as compared to unstimulated cells (Figure 6E).
Together, these data suggested that the substantial proportion
of activated Lck present in resting T cells was sufficient to initiate
TCR signaling and that no further activated Lck was needed.
In view of these findings, we examined the significance of the
existence of high amounts of activated Lck for TCR signaling. We772 Immunity 32, 766–777, June 25, 2010 ª2010 Elsevier Inc.used geldanamycin as a tool to selec-
tively obtain reduced amounts of basally
activated Lck (Figures 5B and 6F) and
then stimulated Jurkat cells with anti-
CD3 for different times, monitoring the
onset and amplitude of CD3-z phosphor-
ylation by anti-pY142-z immunoblotting.
Geldanamycin treatment had no impact
on the protein amount of LAT, ZAP-70,
CD3-z chain, or GAPDH (not shown). An
example of these experiments is shown
in Figure 6F. Cells expressing only
10% of activated Lck, with only half
reduction of total Lck (right panel), showed severely compro-
mised z chain phosphorylation (Figure 6F). Furthermore,
although in control cells induction of pY142-z was recorded as
early as 10 s of stimulation, cells with reduced basal pY394-
Lck demonstrated no recordable z phosphorylation at this early
time point (graph, left). These data suggest that high amounts of
preactivated Lck are essential for the potency and rapidity of
TCR signal propagation.
DISCUSSION
The mechanism regulating the ability of Lck to induce ITAM
phosphorylation, one of the earliest signaling events detected
after TCR ligation, has remained elusive. Although it is commonly
believed that Lck is activated upon TCR and/or coreceptor
engagement, direct proof for this model is lacking. In this study,
we provided strong evidence that resting T cells expressed
relatively high amounts of Lck constitutively phosphorylated
Figure 5. Basal Amounts of Active Lck Are
Regulated by Its Own Kinase Activity and
Binding to the HsP90-CDC37 Chaperone
Complex
(A) Jurkat cells were treated with different concen-
trations of PP2 or its inactive analog PP3. The
amount of pY394-Lck was quantitated by anti-
pY416 immunoblotting at the indicated times.
Error bars represent standard deviation from three
independent experiments.
(B) Jurkat cells were treated with 5 mM Geldana-
mycin, or DMSO as control, for 3 hr at 37C. Cell
lysates were probed with anti-pY416 and anti-
Lck, and GAPDH was used as a loading control.
The histogram on the right represents data
collected from three independent experiments.
(C) Jurkat cells preincubated with 50 mM PP2 or its
inactive analog PP3, or J45 cells, were treated with
5 mM Geldanamycin or DMSO, as in (B). The
amount of Lck was determined by anti-Lck immu-
noblotting and protein loading by GAPDH (not
shown). Error bars represent standard deviation
from three independent experiments
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kinase activity presumably geared up for but uncoupled from
ITAM phosphorylation, appeared to remain unchanged upon
TCR and coreceptor ligation, suggesting that it suffices to initiate
T cell activation. These data are consistent with recent FRET
analysis that detected no Lck conformational changes upon
TCR ligation (Paster et al., 2009). Some studies, but not othersImmunity 32, 766–7(Filipp et al., 2003; Holdorf et al., 2002;
and the present work), have reported
small increases over background in Lck
tyrosine phosphorylation and/or kinase
activity upon TCR stimulation (Burkhardt
et al., 1994). Differences in stimulatory
conditions, cell solubilization, quantita-
tive monitoring of Lck phosphorylation,
and activity changes with a specific
substrate may explain this discrepancy.
In our study, multiple experiments using
different stimulatory settings consistently
revealed no changes in the amount of
basally active Lck. Quantitative SILAC-
based MS of anti-CD3-stimulated Jurkat
cells also found no substantial change
above background in Lck pY394 phos-
phorylation (data not shown). We cannot
rule out that undetectable increases in
activated Lck may take place in the prox-
imity of the TCR, which may be relevant
for ITAM phosphorylation. However, our
data indicate that such a mechanism
would require a pool of pre-existing acti-
vated Lck the abundance of which deter-
mines the level of TCR-induced ITAM
phosphorylation. Imaging studies de-
tected pY394-Lck accumulated at the
immunological synapse minutes afterT cell-APC interaction, presumably because of coreceptor
engagement, which was suggested to reflect stimulation-
induced activation of Lck (Campi et al., 2005; Holdorf et al.,
2002). However, because cells were not imaged prior to APC
contact, it was not documented whether activated Lck was
present before stimulation, as we show in our study. We
detected activated SFKs in T cells in vitro and in situ in all77, June 25, 2010 ª2010 Elsevier Inc. 773
Figure 6. TCR Ligation Does Not Increase
pY394-Lck or Lck Kinase Activity
(A) Jurkat cells stimulated for the indicated times
with anti-CD3. An aliquot was probed with anti-
pY, anti-pY142-z, and anti-pY416. Lck (bottom
panel) was a loading control.
(B) Human CD4+ T cells were added for the indi-
cated times to unpulsed or sAg-pulsed Raji B
cells. Cell activation was detected by pYLAT
and pY142-z as in (A). Lysates were also probed
for pY394-Lck (with anti-pY416) and Lck. The
59 kDa species is mostly Fyn.
(C) 2D1 TCR-tg CD8+ T cells were stimulated with
either unpulsed or PLP peptide-pulsed LPS-acti-
vated B cells from MHC class I HLA-A3 tg mice.
Cell activation and pY394-Lck changes were
monitored as in (B).
(D) 2D1 TCR-tg CD8+ T cells were stimulated for
the indicated times with A3-PLP-MHC class-I
tetramers. Cell activation and pY394 changes
were detected as in (C). Each of these experiments
was performed at least twice.
(E) Confocal IF of purified human CD4+ T cells left
untreated or stimulated with anti-CD3 for 2 min at
37C. Cells were fixed, mixed at a ratio 1:1, and
stained with anti-pY416 (top panels) or anti-
pY505 (bottom panels), revealed by anti-rabbit
Alexa594 (red), and with anti-mouse Alexa488
(green) to detect the presence of anti-CD3. The
histograms represent the average anti-pY416 or
anti-pY505 fluorescence intensity measurements,
in 15 cells, from single-focal planes chosen at
random ± SE (13.26 ± 1.4 and 13.59 ± 1.7 n = 15
ROI. p < 0.05) in unstimulated (CD3) and stimu-
lated (CD3+) cells respectively. The dot plots on
the right represent the distribution of fluorescence
intensity/cell for the same set of cells. The scale
bar represents 5 mm.
(F) Jurkat cells treated for 3 hr with 5 mM Geldana-
mycin, or DMSO as control, were stimulated for
the indicated times with anti-CD3. Cell lysates
were probed with anti-pY142-z and the intensity
of the bands was quantitated by near-infrared
fluorescence. Anti-pY142-z values, normalized
for protein loading (by GAPDH immunoblotting),
were plotted against stimulation time so that
induction of z chain phosphorylation could be
designated. The histogram shows the reduction
on pY394 and total Lck resulting from geldanamy-
cin treatment. One representative experiment out
of three is shown.
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specific regulation of SFK activity in the T cell lineage. In situ
and in vitro data suggest that unstimulated B cells also express
basally activated SFKs, although at lower amounts than T cells
(data not shown).
Activated Lck did not appear to depend on ‘‘tonic stimuli’’ from
the TCR and/or coreceptors and was preserved in unstimulated
cultured lymphocytes. This is consistent with data suggesting
that T cells deprived in vivo of self-MHC contact for prolonged774 Immunity 32, 766–777, June 25, 2010 ª2010 Elsevier Inc.periods of time show intact TCR-induced activation (Fischer
et al., 2007). If TCR and coreceptors do not seem to control
the amount of activated Lck, what then regulates its generation
and maintenance? The high and constitutive PTP activity of
CD45 ensures dephosphorylation at the autoinhibitory site over
Csk action (Palacios and Weiss, 2004) and generates primed
Lck, which we found to be a sizable fraction of the total Lck
pool. Primed Lck is likely to be the precursor that generates acti-
vated Lck by trans-autophosphorylation at pY394. Inhibition of
Immunity
Lck Regulation in T CellsSFK activity by PP2 resulted in a very rapid decay of pY394
amounts, implying that Lck activity is dynamically kept in check
by a potent PTP, most likely CD45 (Irles et al., 2003; McNeill
et al., 2007); yet it has a sufficient kinetic advantage over the
PTP to form relatively high amounts of active Lck. One possibility
is that localization of Lck in membrane domains from which most
CD45 is excluded (Irles et al., 2003) favors the formation of active
Lck. However, additional mechanisms employing regulatory
partners, such as Tsad (Marti et al., 2006) and Unc119 (Gorska
et al., 2004), could contribute to facilitating opening of the kinase
(Boggon and Eck, 2004) and/or collision-induced trans-auto-
phosphorylation.
We also showed that constitutively active wild-type Lck
requires binding to HSP90-CDC37 in order to prevent its degra-
dation. However, this was not the case for the primed and
closed-inactive forms of Lck. Thus, the amount of basally active
Lck is maintained by at least two regulatory mechanisms, a
trans-autophosphorylation exhibiting a sufficient kinetic advan-
tage over the action of a PTP and a balance between HSP90-
CDC37-dependent stabilization and protein degradation.
The naturally occurring DPho-Lck in T cells was open, as
revealed by anti-pY505 binding, and it had kinase activity
comparable to pY394-Y505-Lck. We therefore assume that the
SH2-SH3 module in DPho-Lck is free to bind to substrates and
that its kinase domain is in a fully active conformation. DPho-
Lck may be the consequence of abundant generation of
pY394-Lck in T cells, and at present, we favor the hypothesis
that it derives from pY394-Y505-Lck phosphorylated by Csk.
Indeed, if inactive-closed Lck was the direct precursor of
DPho-Lck, the latter might have remained in a closed conforma-
tion (Moarefi et al., 1997). The presence of DPho-Lck may be the
result of membrane compartmentalization and/or of Lck interact-
ing partners that help preserve phosphorylation of unbound
pY505 in spite of the strong CD45 activity. Although future
studies will address these questions, a consequence of our
findings is that pY505-Lck in T cells does not solely represent
inactive Lck.
In agreement with constitutively activated Lck being used for
ITAM phosphorylation, we showed that reduction of this form
correlated with decreased TCR-induced ITAM phosphorylation.
We estimated that unstimulated normal T cells can express up
to 104 activated Lck molecules, most of which are plasma
membrane bound. This is a high value considering Lck kcat for
CD3-z ITAMs (1–2 s-1) and the high copy number of CD3-z ITAMs
(1.83 105) for 33 104 TCRs. Using a simple model for enzymatic
reactions within the membrane, on the basis of these and other
established values, we estimate that when few TCRs are
engaged, those levels of activated Lck allow phosphorylation
of 3-6 ITAMs on a single TCR within 3–6 s, which is in agreement
with the observed fast kinetics of TCR-triggered signaling (Huse
et al., 2007). If smaller numbers of activated Lck are considered
in our model (e.g., 102–103), then phosphorylation of ITAMs
requires tens of seconds. Consistently, we found that the onset
of CD3-z phosphorylation in response to TCR ligation was
delayed in cells containing strongly reduced (90%) amounts
of activated Lck. Preliminary data of Jurkat cells treated for
different times with geldanamycin showed a very close correla-
tion between the amount of basally activated Lck and the ampli-
tude of CD3-z ITAMs phosphorylation (data not shown). Thus,constitutively activated Lck appears to be required to shorten
the time lapse from ligand binding to ITAM phosphorylation
and to confer high sensitivity to TCR-induced signaling.
A central question emerging from our findings is how activated
Lck is prevented from extensively phosphorylating the ITAMs
(and other receptor tails) in unstimulated cells although it is
‘‘licenced’’ to do so within seconds after TCR ligation. It has
been suggested that TCR intracellular tails interact with acidic
membrane lipids and are exposed to Lck phosphorylation and
ZAP-70 binding only after TCR ligation (Sigalov et al., 2006; Xu
et al., 2008). Moreover, there is evidence for ligand-induced
TCR-a chain conformational (Beddoe et al., 2009) and TCR-
CD3 quaternary changes (Kim et al., 2009), which may lead to
intracellular conformational changes (Gil et al., 2002; Xu et al.,
2008) and to Lck access to the ITAMs. In addition to that, in
T cells SFKs (and coreceptors) are dynamically confined into
liquid-ordered lipid microdomains from which nonengaged
TCRs may be excluded (Douglass and Vale, 2005; He and
Marguet, 2008; Shimada et al., 2005), thus limiting TCR contact
with activated SFKs. TCR ligation may induce conformational
changes and/or changes in the lipid environment around the
TCR (Shimada et al., 2005; Zech et al., 2009), which, together
with concomitant engagement of coreceptor carrying activated
Lck, facilitate TCR ITAM phosphorylation.
In view of the present findings, we propose a ‘‘standby’’ model
for SFKs in T cells, in which regulated amounts of preactivated
Lck, kept under strict control by CD45, are necessary and
sufficient to ensure TCR-induced ITAM phosphorylation. This
model bypasses the need for coreceptor dimerization or oligo-
merisation to activate Lck and may explain TCR signaling in
the absence of coreceptors. One interesting corollary of the
‘‘standby’’ model is that other immune receptors that signal via
highly diverse intracellular tails and use SFKs would not require
individually specialized mechanisms to activate SFKs but would
exploit a common preactivated pool, perhaps by using signal
transduction rules similar to antigen receptors. Finally, our data
reveal the versatility of SFKs regulation, which may have been
specifically adapted for the purpose of lymphocyte activation.EXPERIMENTAL PROCEDURES
Reagents
Reagents, antibodies, and cells used are described in the Supplemental
Information.Immunoprecipitation and Immunoblotting
Cultured cells were rapidly centrifuged and the pellet was immediately lysed
with ice-cold lysis buffer, 20 mM Tris-HCl (pH 7.5), 150 mM NaCl, 1% n-Do-
decyl-b-D-maltoside (LM), 1 mM Na3VO4, and 1 mM phenylmethylsulphonyl
fluoride. n-Dodecyl-b-D-maltoside (LM) quantitatively extracts SFKs from
detergent-resistant membranes (DRMs). Clarified lysates were incubated
with the indicated Abs for 2 hr at 4C and subsequently for 1 hr with protein
A/G-agarose beads (Santa Cruz Biotechnology). Immune complexes were
washed in lysis buffer and boiled in Laemmli sample buffer. For immunodeple-
tion of denatured Lck, cells were lysed in lysis buffer containing 0.4% LM.
Clarified lysates were treated 5 min at 100C in the presence of 1% v/v
SDS, diluted 10-fold by adding 1% LM-containing buffer to quench SDS,
and subjected to three rounds of immunoprecipitation with the indicated
Abs or with normal rabbit or mouse IgG. Lysates and immunoprecipitates
were separated by SDS-PAGE and immunoblots quantified by near-infrared
fluorescence with the Odyssey imaging system (LI-COR Biosciences).Immunity 32, 766–777, June 25, 2010 ª2010 Elsevier Inc. 775
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Lck immunoprecipitates were isolated with the indicated Abs, washed three
times in kinase buffer (20 mM Tris-HCl [pH 7.5], 10 mM MgCl2, 10 mM
MnCl2, and 1 mM ATP), and incubated for 20 min at 37
C in 20 ml of kinase
buffer together with 100 ng of GST-CD3-z. The reaction was stopped by add-
ing 43 Laemmli sample buffer at 100C, and Lck activity was quantified by
near-infrared fluorescence with anti-pY142-z immunoblotting.
Confocal Immunofluorescence
Immunofluorescence staining and confocal microscopy on isolated cells and
tissues is described in the Supplemental Information.
Cell Stimulation and Drug Treatment
A total of 107 purified human CD4+ T cells were incubated at a 3:1 ratio with Raji
B cells, either unpulsed or pulsed with a mixture of 0.5 mg/ml SEA, 0.5 mg/ml
SEB and 0.5 mg/ml SEC for the indicated times at 37C. A total of 3 3 106
Jurkat cells were stimulated at 37C with anti-CD3 (UCHT1) at 10 mg/ml. A total
of 107 TCR transgenic 2D1 CD8 T cells were stimulated at 37C at a ratio 1:1
with LPS-activated HLA-A3 mouse-derived B cells prepulsed with 50 mM PLP
45-53 peptide. 2D1 CD8 T cells were activated by soluble HLA-A3-PLP 45-53
tetramer (Friese et al., 2008) at concentrations that gave saturating staining in
flow cytometry.
Cells were incubated with 5 mM 17- (Allylamino)-17-demethoxy geldanamy-
cin (17-AAG) for 3 hr at 37C and either lysed immediately or stimulated with
anti-CD3 as described above. PP2 was added at increasing concentrations
(10–50 mM) at 37C and the cells were lysed at different time points.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures,
Supplemental Results, and five figures and can be found with this article online
at doi:10.1016/j.immuni.2010.05.011.
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